Chief Accounting Officer
DBV Technologies S.A. (DBVT)Equibles does not estimate personal net worth.
Get an email with a short summary when DBV Technologies S.A. publishes a filing, an earnings call transcript or a press release.
Get DBVT alertsVirginie Boucinha is recorded as Chief Accounting Officer at DBV Technologies S.A. (DBVT) since November 6, 2023 and CFO at DBV Technologies S.A. (DBVT). The newest filing on record that lists Virginie Boucinha as CFO at DBV Technologies S.A. (DBVT) is dated May 11, 2026. DBV Technologies S.A. reported in an 8-K filed October 16, 2023 that Virginie Boucinha was appointed Chief Financial Officer, effective November 6, 2023. The proxy statement of DBV Technologies S.A. reports total compensation of $458,450 for Virginie Boucinha in fiscal 2024, including a base salary of $319,308. Disclosed compensation is on record for 3 fiscal years. Virginie Boucinha has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for DBV Technologies S.A. on October 28, 2026. DBV Technologies S.A. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at DBV Technologies S.A. includes Daniel Tassé (CEO and Board Member), Michel de Rosen (Chairman), Adora Ndu (Board Member) and 7 others.
“On October 16, 2023, DBV Technologies S.A. (the "Company") announced the appointment of Virginie Boucinha as the Company's Chief Financial Officer and principal accounting officer, effective as of November 6, 2023.”
“We ended the third quarter with 165.7 million U.S. dollars in cash and cash equivalents. This includes $50 million in gross proceeds from the sales of ADSs to IRA capital under our refreshed ATM program.”
“Chers actionnaires, chers membres du conseil d'administration, chers partenaires, je vais rendre compte à ce moment de la performance financière de l'entreprise au cours de l'année 2025.”
“We will now briefly review financial highlights for the first semester of 2024. There are two key highlights I would like to elaborate on: our cash run rate and our P&L, particularly operating expenses.”
“And I will now provide a brief overview of our financials for the year 2023, which I invite you to further review in our press release and filings. There are three highlights I would like to point out for year 2023.”
2023-11-06–present
Start not stated–present
Last confirmed May 11, 2026
Biotechnology · Healthcare
CFO, Chief Accounting Officer
2023-11-06–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | DBV Technologies S.A. (DBVT) | Chief Financial Officer | $319,308 | $458,450 |
| 2023 | DBV Technologies S.A. (DBVT) | Chief Financial Officer | $49,539 | $234,630 |
| 2022 | DBV Technologies S.A. (DBVT) | Chief Financial Officer | — | — |
